Breast Cancer Alliance awards $1.4M to 21 grantees in 2026

Breast Cancer Alliance announced its 2026 class of 21 grantees, totaling more than $1.4 million for breast cancer research, surgical training and community screening access. The announcement lands during the nonprofit’s 30th anniversary and brings its lifetime giving to nearly $40 million.

Why it matters: - Breast Cancer Alliance is directing new money to three pressure points in breast cancer care: early-stage research, surgeon training and screening access. - The grants are meant to help patients through better treatments, stronger surgical expertise and more available mammography in underserved communities. - The 2026 awards come as Breast Cancer Alliance marks 30 years of work, signaling a milestone moment for the Greenwich, Connecticut-based nonprofit.

What happened: - Breast Cancer Alliance announced its Class of 2026 grantees on Sept. 10, 2026. - The nonprofit selected 21 recipients across three flagship grant programs. - The 2026 package totals $1.4 million. - Breast Cancer Alliance said the awards support scientists, surgeons and hospitals working to improve breast cancer care. - Breast Cancer Alliance was founded in 1996 in Greenwich, Connecticut. - The organization has distributed close to $40 million across 584 grants since its founding.

The details: - The Young Investigator Grant program funds early-career scientists pursuing breast cancer research that may not yet qualify for traditional public funding. - The 2026 Young Investigator recipients are Ang Cui, PhD, at the Broad Institute of MIT & Harvard; Jonathan Tsai, MD, PhD, at Brigham & Women’s Hospital; and Anli Zhang, PhD, at UT Southwestern Medical Center. - The Exceptional Project Grant program supports tenured scientists and established researchers studying breast cancer biology, diagnostics and treatment. - The 2026 Exceptional Project recipients are Hanna Irie, MD, PhD, at Icahn School of Medicine at Mount Sinai; Huiping Liu, MD, PhD, at Northwestern University Feinberg School of Medicine; Richard Pomerantz, MD, at Thomas Jefferson University; and Matthew G. Vander Heiden, MD, PhD, at Massachusetts Institute of Technology. - The Breast Surgical Oncology Fellowship program funds one-year post-medical school fellowships at Society of Surgical Oncology-accredited institutions. - Breast Cancer Alliance is the only U.S. nonprofit funding those fellowships. - The 2026 fellows are Nora Claire Elson, MD, at The Mount Sinai Hospital; Amanda Nash, MD, at Memorial Sloan Kettering Cancer Center; Maya Petashnick, MD, at Yale University; Naina Rao, MD, at Rutgers Cancer Institute; and Cherease Rhea Nicla Street, MD, at Montefiore Medical Center. - The Screening & Diagnostics grant program funds free and low-cost mammography and diagnostic services at community hospitals in Connecticut and New York. - The 2026 hospital grantees are Danbury Hospital & New Milford Hospital; Greenwich Hospital; Griffin Hospital; Hartford Hospital; Hospital of Central Connecticut; Norma Pfriem Breast Cancer Center at Bridgeport Hospital; Norwalk Hospital; Stamford Hospital; and White Plains Hospital. - The grant program includes named gifts tied to donors, families and corporate partners. - The 2026 class reflects thirteen named gifts from the Rodkin Family, the Gabelli Foundation, Pitch Your Peers, Veronica Beard, the Deutsch Family Foundation, the Deborah G. Black Memorial Fund, Stuart & Jane Weitzman, the Robert G. Burton Charitable Foundation, the Chambers Family Foundation, the Michele Helie Millard Memorial Fund, the Mitchell Family and OMNICOM.

Between the lines: - The grant mix shows Breast Cancer Alliance is spreading support across the research pipeline, from early discovery to specialized clinical training and community screening. - The fellowship program addresses a narrow training gap, with fewer than 1% of American surgeons completing dedicated breast surgical oncology fellowships. - The screening grants point to a continued focus on access barriers tied to geography and income. - Lori Kron, Breast Cancer Alliance president, said the Class of 2026 reflects the organization’s top scientists, future surgeons and community programs, and thanked donors, sponsors and supporters for making the grants possible.

What's next: - Breast Cancer Alliance said more information on the 2026 grantee class is available at the organization’s website. - The nonprofit’s donor-backed model suggests future grant rounds will continue to depend on named gifts and philanthropic support. - The 2026 fellows, researchers and hospitals are expected to use the funding to advance studies, training and screening services over the coming year.

The bottom line: - Breast Cancer Alliance is using a milestone year to widen its footprint across breast cancer research, surgical training and screening access, with 21 grants aimed at improving care now and in the next generation.